Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy

2021 ◽  
Author(s):  
Nijole Bernaitis ◽  
Tony Badrick ◽  
Shailendra Anoopkumar-Dukie
Keyword(s):  
Atrial Fibrillation ◽  
Drug Interactions ◽  
Anticoagulant Therapy ◽  
Vitamin K ◽  
Oral Anticoagulant ◽  
Oral Anticoagulant Therapy ◽  
Pharmacokinetic Drug

scholarly journals Oral anticoagulant therapy management after successful atrial fibrillation ablation

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P538-P538
Author(s):  
C. Gallo ◽  
A. Battaglia ◽  
D. Sardi ◽  
E. Toso ◽  
D. Castagno ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Anticoagulant Therapy ◽  
Oral Anticoagulant ◽  
Oral Anticoagulant Therapy ◽  
Atrial Fibrillation Ablation ◽  
Therapy Management

scholarly journals The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

2012 ◽  
Vol 34 (3) ◽  
pp. 170-176 ◽  
Author(s):  
Michiel Coppens ◽  
John W. Eikelboom ◽  
Robert G. Hart ◽  
Salim Yusuf ◽  
Gregory Y.H. Lip ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Anticoagulant Therapy ◽  
Oral Anticoagulant ◽  
Oral Anticoagulant Therapy ◽  
Chads2 Score
Sign in / Sign up

Export Citation Format

Share Document